American Healthcare REIT (AHR)

NYSE Real Estate Health Care REITs S&P MidCap 400
$57.91
+1.87 (+3.34%)
Close of Nov 06, 2026 · end-of-day data
Source: American Healthcare REIT's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$0$5.56M$36.86M$1.10B$1.07B$1.12B$1.41B$1.67B$1.88B$2.09B
Cost of revenue$898.00K$7.29M$11.50M$19.23M$993.73M$1.03B$1.28B$1.50B$1.65B$1.79B
Gross profit-$898.00K-$1.73M$25.36M$1.08B$75.35M$93.74M$130.63M$166.43M$229.91M$300.98M
Operating income-$4.96M——$221.40M$218.28M$213.34M$301.96M$306.83M$363.54M$415.16M
Interest expense$514.00K$2.70M$6.79M$78.55M$71.28M$80.94M$105.96M$163.19M$127.73M$85.78M
Pre-tax income-$5.47M$508.00K-$8.58M$672.00K$5.79M-$52.31M-$72.80M-$76.22M-$33.89M$48.65M
Income tax$0$0$8.00K$1.52M-$3.08M$956.00K$586.00K$663.00K$1.71M-$22.17M
Net income-$5.47M$541.00K-$8.35M-$4.96M$2.16M-$47.79M-$81.30M-$71.47M-$37.81M$69.81M
EBITDA-$3.71M——$332.81M$317.13M$346.53M$469.92M$489.44M$542.73M$602.72M
EPS (basic)$-1.75$0.02$-0.15$-0.03$0.05$-0.95$-1.24$-1.08$-0.29$0.42
EPS (diluted)$-1.75$0.02$-0.15$-0.03$0.05$-0.95$-1.24$-1.08$-0.29$0.42
Diluted shares3.13M27.75M54.85M181.93M44.98M50.08M65.81M66.05M130.64M166.85M
Gross margin—-31.1%68.8%98.3%7.0%8.3%9.3%10.0%12.2%14.4%
Operating margin———20.1%20.4%19.0%21.4%18.4%19.3%19.8%
Net margin—9.7%-22.7%-0.5%0.2%-4.3%-5.8%-4.3%-2.0%3.3%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$2.24M$7.09M$35.13M$53.15M$113.21M$81.60M$65.05M$43.45M$76.70M$114.84M
Inventory————$24.67M$18.93M$19.77M$19.47M$19.48M$18.84M
Goodwill————$75.31M$209.90M$231.61M$3.33M$234.94M$234.94M
Total assets$142.76M$480.15M$896.37M$1.07B$3.23B$4.58B$4.79B$4.58B$4.49B$5.43B
Total liabilities$50.50M$125.93M$337.33M$476.79M$2.16B$2.75B$3.14B$3.12B$2.18B$2.07B
Shareholders' equity$92.25M$353.22M$1.22B$590.08M$866.11M$1.58B$1.40B$1.27B$2.26B$3.32B

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow-$3.62M$12.40M$15.42M$117.45M$219.16M$17.91M$147.77M$98.53M$176.09M$294.44M
Capital expenditures$23.00K$1.12M$4.26M$6.50M——$7.54M———
Free cash flow-$3.64M$11.28M$11.17M$110.96M$219.16M$17.91M$140.22M$98.53M$176.09M$294.44M
Investing cash flow-$133.32M-$330.69M-$411.55M-$103.11M-$147.94M-$138.65M-$118.58M$9.40M-$8.73M-$1.08B
Financing cash flow$138.98M$323.15M$403.62M$2.69M-$8.81M$94.11M-$42.92M-$129.06M-$134.74M$817.24M
Dividends paid$549.00K$6.40M$13.99M$62.61M$27.00M$22.79M$51.12M$76.28M$120.89M$163.52M
Share buybacks$0$735.00K$3.31M$89.89M$23.11M$382.00K$20.70M$469.00K$14.00K$0
Stock-based compensation$80.00K$131.00K$185.00K$2.74M-$1.34M$8.80M$3.91M$5.47M$9.87M$14.62M
Depreciation & amortization$1.25M$13.64M$32.66M$111.41M$98.86M$133.19M$167.96M$182.60M$179.19M$187.56M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.